Clinical trial
Establishment of Precise Histological Evaluation Criteria for Reversal of NASH Fibrosis
NCT06707129 is registered in ClinicalTrials.gov with Beijing Municipal Administration of Hospitals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Establishment of Precise Histological Evaluation Criteria for Reversal of NASH Fibrosis
- Lead sponsor
- Beijing Municipal Administration of Hospitals
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 1, 2024
- Completion date
- August 31, 2027
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.